Viewing Study NCT04631835


Ignite Creation Date: 2025-12-24 @ 10:22 PM
Ignite Modification Date: 2026-01-31 @ 3:55 PM
Study NCT ID: NCT04631835
Status: UNKNOWN
Last Update Posted: 2022-06-15
First Post: 2020-11-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None dose-escalation View
None advanced solid tumors View
None estrogen receptor positive breast cancer View
None PIK3CA gene mutation View